126 results
Page 2 of 7
8-K
EX-99.1
z3juqb6ohh9 zf6hviod
5 Oct 23
Apellis Announces Preliminary U.S. Net Revenues of Approximately $74 Million for SYFOVRE® (pegcetacoplan injection) in the Third Quarter of 2023
7:15am
8-K
EX-1.1
t2hl14 q6dza
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm